1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Parmax Pharma Ltd
Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
25.93% Gain from 52W Low
-7.6
TTM PE Ratio
Negative PE TTM
-2.8
Price to Book Ratio
Low in industry
1.7
Dividend yield 1yr %
0
TTM PEG Ratio
0
RSI
RSI is mid-range
50.7
MFI
MFI is mid-range
56.5
Parmax Pharma Ltd Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
30.30
10Day EMA
30.20
12Day EMA
30.20
20Day EMA
30.20
26Day EMA
30.30
50Day EMA
30.60
100Day EMA
30.90
200Day EMA
31.30
5Day SMA
30.30
10Day SMA
30.00
20Day SMA
30.40
30Day SMA
30.10
50Day SMA
30.50
100Day SMA
31.30
150Day SMA
31.10
200Day SMA
30.80
Resistance & Support
30.45
Pivot
Resistance
First Resistance
32.49
Second Resistance
34.54
Third Resistance
36.58
Support
First Support
28.40
Second support
26.36
Third Support
24.31
Relative Strength Index
50.66
Money Flow Index
56.54
MACD
-0.07
MACD Signal
-0.11
Average True Range
2.33
Average Directional Index
18.10
Rate of Change (21)
6.92
Rate of Change (125)
-1.04
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
Chemo Pharma Laboratories Ltd. | - | - | - | |
Colinz Laboratories Ltd. | - | - | - | |
Kobo Biotech Ltd. | - | - | - | |
Unjha Formulations Ltd. | - | - | - | |
Ganga Pharmaceuticals Ltd. | - | - | - | |
Norris Medicines Ltd. | - | - | - | |
Parmax Pharma Ltd. | - | - | - |
Parmax Pharma Ltd Company background
Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Parmax Pharma Ltd FAQs
How can I buy Parmax Pharma Ltd shares?
You can easily buy Parmax Pharma Ltd shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Open Demat Account
or Resume your Application
